Trademark: 76672205
Word
BIORENUE
Status
Dead
Status Code
602
Status Date
Monday, April 28, 2008
Serial Number
76672205
Mark Type
4000
Filing Date
Friday, February 2, 2007
Abandoned Date
Sunday, March 30, 2008

Trademark Owner History

Classifications
5 Vitamins, mineral supplements, herbal supplements; neutraceutical preparations for use as a dietary supplement for the maintenance of health; enzyme preparations for use as a dietary supplement for the maintenance of health; neutraceutical preparations for use in the treatment of blood and hemic diseases and disorders, cardiological and heart diseases and disorders, congenital and genetic diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immune diseases and disorders, infectious diseases and disorders, lymphatic diseases and disorders, metabolic diseases and disorders, musculoskeletal, skeleton and muscle, neoplastic and cancerous diseases and disorders, neurologic and nerve diseases and disorders, nutritional diseases and disorders, optic and eye diseases and disorders, reproductive disease and disorders, respiratory diseases and disorders, skin diseases and disorders, urinary diseases and disorders, and viral diseases and disorders

Trademark Events
Apr 28, 2008
Abandonment Notice Mailed - Failure To Respond
Apr 28, 2008
Abandonment - Failure To Respond Or Late Response
Oct 11, 2007
Assigned To Examiner
Oct 2, 2007
Combined Examiner's Amendment/Priority Action Entered
Oct 1, 2007
Examiner's Amendment/Priority Action Mailed
Oct 1, 2007
Examiners Amendment And/Or Priority Action - Completed
Aug 1, 2007
Final Refusal Mailed
Aug 1, 2007
Final Refusal Written
Jul 7, 2007
Amendment From Applicant Entered
Jul 7, 2007
Correspondence Received In Law Office
Jul 7, 2007
Assigned To Lie
Jun 25, 2007
Paper Received
May 29, 2007
Non-Final Action Mailed
May 29, 2007
Non-Final Action Written
May 22, 2007
Assigned To Examiner
Feb 13, 2007
Application Filing Receipt Mailed
Feb 9, 2007
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24